Need a different choice for IDA in CKD-NDD?
Reach for AURYXIA.
CKD=chronic kidney disease; IDA=iron deficiency anemia; NDD=non-dialysis dependent. *Not specifically indicated.
AURYXIA is the first oral iron specifically indicated for adults with CKD not on dialysis1
AURYXIA has been proven to increase Hb and iron parameters (TSAT and ferritin) with a starting dose of 1 tablet 3 times a day.1-4†‡ So your clinical interests—and your patients’ interests—line up.
In the clinical trial:
- Mean Hb increased from 10.4 g/dL to 11.4 g/dL by the end of the 16-week period2,3
- Mean TSAT increased from 20.2% at baseline to 35.6% at Week 164
- Patients on AURYXIA also achieved a mean increase in serum ferritin of 163 ng/mL from baseline (85.9 ng/mL) at Week 161,2
Hb=hemoglobin; TSAT=transferrin saturation.
†IV iron use and ESA use were not allowed per trial design and exclusion criteria.1
‡In the clinical trial, patients required an average of 5 tablets per day to increase hemoglobin levels.
*Not specifically indicated.